Picking a Fight with Calcium. Scoring a $1B TKO.
Cardiovascular Systems, Inc. had a bold product, an aggressive culture, and a brand that wasn’t keeping up. Multiple product names. Fragmented messaging. A sales force that needed something to rally behind.
F&N Med gave them one thing: an enemy.
The Challenge
CSI had developed a revolutionary atherectomy device capable of treating complex calcified lesions that other technologies couldn’t touch. The science was exceptional. The clinical data was compelling. But the brand was scattered — different names, different messages, different stories depending on who you asked.
The Idea
Through deep brand and market exploration, one truth emerged. The enemy wasn’t the competition. The enemy was calcium.
“Simple physics defeats complex calcium.”
That single belief became the organizing principle for everything that followed.
The Work
From campaign site to mobile sales tool to trade show floor to patient awareness — every touchpoint became a battle cry. The brand gave the sales force a unified story, gave physicians a clear rationale, and gave the market a reason to believe.
The Result
The most successful product launch in company history. And a brand strong enough to attract the attention of one of MedTech’s biggest players.
In 2022, Abbott acquired Cardiovascular Systems, Inc. in a deal valued at over $1 billion.
This is what belief-driven branding does for enterprise value. See our case study here at the F&N Med page.